Omega First
Natural health product licensed in Canada
- Other names
- Health First - Omega First
- Licence holder
- Accurex Health Care Manufacturing Inc.
- NPN or DIN-HM
- 80004324
- Status
- Active licence
- Licence date
- 24 October 2007
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Extrait d'oléorésine de romarin, Vitamine E, Huile de fève de soja, Natural lemon oil flavour
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 1 year ; maximum: 18 years | 2 Capsule | Not specified |
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids for the maintenance of good health. Source of EPA and DHA for the maintenance of good health. Helps support cognitive health/brain function. . Helps maintain / support cardiovascular health. Helps to reduce serum triglycerides / triacylglycerols. Helps support the development of the brain, eyes, and nerves (for children aged 18 and under).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80004324
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.